Effects of ionizing radiation in biomolecules, cells and tissue/organs: basic mechanisms and applications for cancer therapy, medical imaging and radiation protection

Francesca Ballarini; Mario P. Carante; Alessia Embriaco; Ricardo L. Ramos; Francesca Ballarini; Mario P. Carante; Alessia Embriaco; Ricardo L. Ramos

doi:10.3934/biophy.2022010

AIMS Biophysics

2022, Volume 9, Issue 2: 108-112. doi: 10.3934/biophy.2022010

Previous Article Next Article

Editorial Special Issues

Effects of ionizing radiation in biomolecules, cells and tissue/organs: basic mechanisms and applications for cancer therapy, medical imaging and radiation protection

1.
Department of Physics, University of Pavia, via Bassi 6, I-27100 Pavia, Italy
2.
INFN–Section of Pavia, via Bassi 6, I-27100 Pavia, Italy
3.
ENEA, Istituto Nazionale di Metrologia delle Radiazioni Ionizzanti, Roma, Italy

Received: 19 April 2022 Revised: 20 April 2022 Accepted: 21 April 2022 Published: 21 April 2022

Citation: Francesca Ballarini, Mario P. Carante, Alessia Embriaco, Ricardo L. Ramos. Effects of ionizing radiation in biomolecules, cells and tissue/organs: basic mechanisms and applications for cancer therapy, medical imaging and radiation protection[J]. AIMS Biophysics, 2022, 9(2): 108-112. doi: 10.3934/biophy.2022010

Related Papers:

References

[1]	Hall E, Giaccia A (2018) Radiobiology for the Radiologist.Lippincott Williams & Wilkins.
[2]	Ottolenghi A, Ballarini F, Merzagora M (1999) Modelling radiation induced biological lesions: from initial energy depositions to chromosome aberrations. Radiat Environ Bioph 38: 1-13. https://doi.org/10.1007/s004110050132
[3]	Cornforth MN, Bedford JS (1987) A quantitative comparison of potentially lethal damage repair and the rejoining of interphase chromosome breaks in low passage normal human fibroblasts. Radiat Res 111: 385-405. https://doi.org/10.2307/3576926
[4]	Cotran RS, Kumar V, Robbins SL (1989) Pathological basis of disease. Philadelphia: WB Saunders.
[5]	Ballarini F, Ottolenghi A (2004) A model of chromosome aberration induction and chronic myeloid leukaemia incidence at low doses. Radiat Environ Bioph 43: 165-171. https://doi.org/10.1007/s00411-004-0246-7
[6]	Ballarini F, Alloni D, Facoetti A, et al. (2006) Modelling radiation-induced bystander effect and cellular communication. Radiat Prot Dosim 122: 244-251. https://doi.org/10.1093/rpd/ncl446
[7]	Particle Therapy Co-Operative Group. Available from: http://www.ptcog.ch
[8]	Scholz M, Kellerer AM, Kraft-Weyrather W, et al. (1997) Computation of cell survival in heavy ion beams for therapy. Radiat Environ Bioph 36: 59-66. https://doi.org/10.1007/s004110050055
[9]	Inaniwa T, Kanematsu N, Matsufuji N, et al. (2015) Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences, Japan. Phys Med Biol 60: 3271. https://doi.org/10.1088/0031-9155/60/8/3271
[10]	Ballarini F, Carante MP (2016) Chromosome aberrations and cell death by ionizing radiation: Evolution of a biophysical model. Radiat Phys Chem 128: 18-25. https://doi.org/10.1016/j.radphyschem.2016.06.009
[11]	Ballarini F, Battistoni G, Campanella M, et al. (2006) The FLUKA code: an overview. J Phys: Conf Series 41: 151-160. https://doi:10.1088/1742-6596/41/1/014
[12]	Carante MP, Ballarini F (2016) Calculating variations in biological effectiveness for a 62 MeV proton beam. Front Oncol 6: 76. https://doi.org/10.3389/fonc.2016.00076
[13]	Carante MP, Aimè C, Cajiao JJT, et al. (2018) BIANCA, a biophysical model of cell survival and chromosome damage by protons, C-ions and He-ions at energies and doses used in hadrontherapy. Phys Med Biol 63: 075007. https://orcid.org/0000-0002-6629-3382
[14]	Carante MP, Aricò G, Ferrari A, et al. (2019) First benchmarking of the BIANCA model for cell survival prediction in a clinical hadron therapy scenario. Phys Med Biol 64: 215008. https://doi.org/10.1088/1361-6560/ab490f
[15]	Carante MP, Aricò G, Ferrari A, et al. (2020) In vivo validation of the BIANCA biophysical model: Benchmarking against rat spinal cord RBE data. Int J Mol Sci 21: 3973. https://doi.org/10.3390/ijms21113973
[16]	Carante MP, Embriaco A, Aricò G, et al. (2021) Biological effectiveness of He-3 and He-4 ion beams for cancer hadrontherapy: a study based on the BIANCA biophysical model. Phys Med Biol 66: 195009. https://doi.org/10.1088/1361-6560/ac25d4
[17]	Kozlowska W, Carante M, Aricò G, et al. (2022) First application of the BIANCA model to carbon-ion patient cases. Phys Med Biol . In press
[18]	Demaria S, Coleman CN, Formenti SC (2016) Radiotherapy: changing the game in immunotherapy. Trends Cancer 2: 286-294. https://doi.org/10.1016/j.trecan.2016.05.002
[19]	Colangelo NW, Azzam EI (2020) The importance and clinical implications of FLASH ultra-high dose-rate studies for proton and heavy ion radiotherapy. Radiat Res 193: 1-4. https://doi.org/10.1667/RR15537.1
[20]	Durante M, Cucinotta FA (2011) Physical basis of radiation protection in space travel. Rev Mod Phys 83: 1245. https://doi.org/10.1103/RevModPhys.83.1245
[21]	Ballarini F, Battistoni G, Cerutti F, et al. (2006) GCR and SPE organ doses in deep space with different shielding: Monte Carlo simulations based on the FLUKA code coupled to anthropomorphic phantoms. Adv Space Res 37: 1791-1797. https://doi.org/10.1016/j.asr.2006.03.007
[22]	Campa A, Alloni D, Antonelli F, et al. (2009) DNA fragmentation induced in human fibroblasts by 56Fe ions: experimental data and Monte Carlo simulations. Radiat Res 171: 438-445. https://doi.org/10.1667/RR1442.1
[23]	Ottolenghi A, Ballarini F, Biaggi M (2001) Modelling chromosomal aberration induction by ionising radiation: the influence of interphase chromosome architecture. Adv Space Res 27: 369-382. https://doi.org/10.1016/S0273-1177(01)00004-7
[24]	Ballarini F, Ottolenghi A (2003) Chromosome aberrations as biomarkers of radiation exposure: modelling basic mechanisms. Adv Space Res 31: 1557-1568. https://doi.org/10.1016/S0273-1177(03)00091-7
[25]	Embriaco A, Ramos R, Carante M, et al. (2021) Healthy tissue damage following cancer ion therapy: a radiobiological database predicting lymphocyte chromosome aberrations based on the BIANCA biophysical model. Int J Mol Sci 22: 10877. https://doi.org/10.3390/ijms221910877
[26]	Stram DO, Sposto R, Preston D, et al. (1993) Stable chromosome aberrations among A-bomb survivors: An update. Radiat Res 136: 29-36. https://doi.org/10.2307/3578636
[27]	Nakano M, Kodama Y, Ohtaki K, et al. (2001) Detection of stable chromosome aberrations by FISH in A-bomb survivors: comparison with previous solid Giemsa staining data on the same 230 individuals. Int J Radiat Biol 77: 971-977. https://doi.org/10.1080/09553000110050065
[28]	Bauchinger M, Schmid E, Braselmann H (2001) Time-course of translocation and dicentric frequencies in a radiation accident case. Int J Radiat Biol 77: 553-557. https://doi.org/10.1080/09553000010022382
[29]	George K, Willingham V, Wu H, et al. (2002) Chromosome aberrations in human lymphocytes induced by 250 MeV protons: Effects of dose, dose rate and shielding. Adv Space Res 30: 891-899. https://doi.org/10.1016/S0273-1177(02)00406-4
[30]	Durante M, Yamada S, Ando K, et al. (2000) X-rays vs. carbon-ion tumor therapy: cytogenetic damage in lymphocytes. Int J Radiat Oncol Biol Phys 47: 793-798. https://doi.org/10.1016/S0360-3016(00)00455-7

Reader Comments

Your name:*

Email:*
© 2022 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)